Presentation/Webcast

Past Presentation

FY2025

Financial results for FY2025

• May 13, 2026 Conference on FY2025​ Financial Results（PDF/1,054KB）
• May 13, 2026 Conference on FY2025 Financial Results (Webcast, available for 12 months)
• May 13, 2026 Conference on FY2025 Financial Results transcript（PDF/5,711KB）
• Jan. 30, 2026 Conference on Q3 FY2025 Financial Results（PDF/741KB）
• Jan. 30, 2026 Conference on Q3 FY2025 Financial Results (Webcast, available for 12 months)
• Jan. 30, 2026 Conference on Q3 FY2025 Financial Results transcript（PDF/3,079KB）
• Oct. 31, 2025 Conference on Q2 FY2025 Financial Results（PDF/688KB）
• Oct. 31, 2025 Conference on Q2 FY2025 Financial Results (Webcast, available for 12 months)
• Oct. 31, 2025 Conference on Q2 FY2025 Financial Results transcript（PDF/4,809KB）
• Jul. 31, 2025 Conference on Q1 FY2025 Financial Results（PDF/925KB）
• Jul. 31, 2025 Conference on Q1 FY2025 Financial Results transcript（PDF/6,344KB）

Presentation Material (Boost 2028 - Accelerating Strong Sumitomo Pharma -)

• Mar. 02, 2026 Conference on Boost 2028 - Accelerating Strong Sumitomo Pharma -（PDF/3,386KB）
• Mar. 02, 2026 Conference on Boost 2028 - Accelerating Strong Sumitomo Pharma - (Webcast, available for 12 months)
• Mar. 02, 2026 Conference on Boost 2028 - Accelerating Strong Sumitomo Pharma - transcript（PDF/6,256KB）

R&D Meeting (2026)

• Feb. 17, 2026 R&D Meeting（PDF/2,493KB）
• Feb. 17, 2026 R&D Meeting (Webcast, available for 12 months)
• Feb. 17, 2026 R&D Meeting transcript（PDF/5,926KB）

FY2024

Financial results for FY2024 and​ Reboot 2027

• May 13, 2025 Conference on FY2024​ Financial Results and​ Reboot 2027 – Reboot for a Strong Sumitomo Pharma –​（PDF/4,377KB）
• May 13, 2025 Conference on FY2024​ Financial Results and​ Reboot 2027 – Reboot for a Strong Sumitomo Pharma – transcript​（PDF/8,903KB）
• Jan. 31, 2025 Conference on Q3 FY2024 Financial Results（PDF/3,013KB）
• Jan. 31, 2025 Conference on Q3 FY2024 Financial Results transcript（PDF/3,883KB）
• Oct. 30, 2024 Conference on Q2 FY2024 Financial Results（PDF/1,396KB）
• Oct. 30, 2024 Conference on Q2 FY2024 Financial Results transcript（PDF/4,744KB）
• Jul. 31, 2024 Conference on Q1 FY2024 Financial Results（PDF/957KB）
• Jul. 31, 2024 Conference on Q1 FY2024 Financial Results transcript（PDF/3,830KB）

Presentation for the Conference on the Establishment of RACTHERA, the Regenerative Medicine and Cell Therapy Business Joint Venture

• Dec. 17, 2024 Presentation Material (Sumitomo Chemical Co., Ltd. )（PDF/671KB）
• Dec. 17, 2024 Presentation Material (Sumitomo Pharma Co., Ltd. )（PDF/552KB）
• Dec. 17, 2024 Conference on the Establishment of RACTHERA, the Regenerative Medicine and Cell Therapy Business Joint Venture transcript（PDF/6,166KB）

FY2023

Financial results for FY2023

• May 14, 2024 Conference on FY2023 (April 1, 2023 to March 31, 2024) Financial Results（PDF/1,202KB）
• May 14, 2024 Conference on FY2023 (April 1, 2023 to March 31, 2024) Financial Results transcript（PDF/5,126KB）
• Jan. 31, 2024 Conference on Q3 FY2023 Financial Results（PDF/1,947KB）
• Jan. 31, 2024 Conference on Q3 FY2023 Financial Results transcript（PDF/6,342KB）
• Oct. 31, 2023 Conference on Q2 FY2023 Financial Results（PDF/514KB）
• Oct. 31, 2023 Conference on Q2 FY2023 Financial Results transcript（PDF/4,550KB）
• Jul. 31, 2023 Conference on Q1 FY2023 Financial Results（PDF/608KB）
• Jul. 31, 2023 Conference on Q1 FY2023 Financial Results transcript（PDF/3,972KB）

Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 Presentation

• May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 （PDF/1,371KB）
• May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 transcript（PDF/1,159KB）

FY2022

Financial results for FY2022

• May 15, 2023 Investors Meeting Presentation for FY2022 (Year ended March 31, 2023)（PDF/672KB）
• May 15, 2023 Investors Meeting Presentation for FY2022 (Year ended March 31, 2023) transcript（PDF/8,751KB）
• Jan. 31, 2023 Q3 FY2022 Conference Call（PDF/437KB）
• Jan. 31, 2023 Q3 FY2022 Conference Call transcript（PDF/8,921KB）
• Nov. 01, 2022 Investors Meeting Presentation for Q2 FY2022（PDF/583KB）
• Nov. 01, 2022 Investors Meeting Presentation for Q2 FY2022 transcript（PDF/6,056KB）
• Jul. 29, 2022 Q1 FY2022 Conference Call（PDF/413KB）
• Jul. 29, 2022 Q1 FY2022 Conference Call transcript（PDF/1,785KB）

ESG Meeting (2022)

• Dec. 13, 2022 ESG Meeting (Discussion with Investors)（PDF/408KB）
• Dec. 13, 2022 ESG Meeting (Discussion with Investors) transcript（PDF/3,346KB）

Mid-term Business Plan 2027 Presentation

• Apr. 28, 2023 Mid-term Business Plan 2027（PDF/4,790KB）
• Apr. 28, 2023 Mid-term Business Plan 2027 Presentation transcript（PDF/26,371KB）

FY2021

Financial results for FY2021

• May 16, 2022 Investors Meeting Presentation for FY2021 (Year ended March 31, 2022)（PDF/913KB）
• May 16, 2022 Investors Meeting Presentation for FY2021 (Year ended March 31, 2022) transcript（PDF/3,792KB）
• Jan. 31, 2022 Q3 FY2021 Conference Call（PDF/1,157KB）
• Jan. 31, 2022 Q3 FY2021 Conference Call transcript（PDF/10,336KB）
• Oct. 28, 2021 Investors Meeting Presentation for Q2 FY2021（PDF/1,252KB）
• Oct. 28, 2021 Investors Meeting Presentation for Q2 FY2021 transcript（PDF/2,392KB）
• Jul. 29, 2021 Q1 FY2021 Conference Call（PDF/972KB）
• Jul. 29, 2021 Q1 FY2021 Conference Call transcript（PDF/751KB）

ESG Meeting (2021)

• Dec. 08, 2021 ESG Meeting (Discussion with Investors)（PDF/2,718KB）
• Dec. 08, 2021 ESG Meeting (Discussion with Investors) transcript（PDF/4,744KB）

Frontier Business Meeting - FBO Showcase -

• Sep. 08, 2021 Frontier Business Meeting - FBO Showcase -
• Sep. 08, 2021 Frontier Business Meeting - FBO Showcase - transcript（PDF/18,633KB）

FY2020

Financial results for FY2020

• May 13, 2021 Investors Meeting Presentation for FY2020 (Year ended March 31, 2021) and Revision of Mid-term Business Plan 2022（PDF/2,289KB）
• May 13, 2021 Investors Meeting for FY2020 and Revision of Mid-term Business Plan 2022 transcript（PDF/4,491KB）
• Jan. 28, 2021 Q3 FY2020 Conference Call（PDF/937KB）
• Oct. 29, 2020 Investors Meeting Presentation for Q2 FY2020（PDF/1,169KB）
• Jul. 30, 2020 Q1 FY2020 Conference Call（PDF/1,043KB）

Sumitovant Meeting

• Mar. 23, 2021 Sumitovant Meeting（PDF/6,694KB）
• Mar. 23, 2021 Sumitovant Meeting transcript（PDF/122KB）

ESG Meeting (2020)

• Dec. 18, 2020 ESG Meeting (Discussion with Investors)（PDF/2,407KB）
• Dec. 18, 2020 Panel Discussion and Q&A Session at the ESG Meeting（PDF/115KB）

FY2019

Financial results for FY2019

• May 14, 2020 Investors Meeting Presentation for FY2019（PDF/1,657KB）
• Jan. 30, 2020 Q3 FY2019 Conference Call（PDF/1,386KB）
• Nov. 01, 2019 Investors Meeting Presentation for Q2 FY2019 (April 1 to September 30, 2019) / Definitive Agreement for Strategic Alliance with Roivant Sciences（PDF/1,705KB）
• Jul. 29, 2019 Q1 FY2019 Conference Call（PDF/582KB）

R&D Meeting (2020)

• Mar. 03, 2020 R&D Meeting（PDF/10,285KB）

ESG Meeting (2019)

• Nov. 27, 2019 ESG Meeting (Discussion with Investors)（PDF/2,758KB）
• Nov. 27, 2019 Q&A Session at the ESG Meeting (Discussion with Investors)（PDF/141KB）

Memorandum of Understanding for Strategic Alliance with Roivant Sciences

• Sep. 06, 2019 Memorandum of Understanding for Strategic Alliance with Roivant Sciences（PDF/481KB）

Mid-term Business Plan 2022 Presentation

• Apr. 12, 2019 Mid-term Business Plan 2022（PDF/4,486KB）

FY2018

Financial results for FY2018

• May 13, 2019 Investors Meeting Presentation for FY2018（PDF/608KB）
• Jan. 31, 2019 Q3 FY2018 Conference Call（PDF/590KB）
• Oct. 31, 2018 Investors Meeting Presentation for Q2 FY2018（PDF/739KB）
• Jul. 27, 2018 Q1 FY2018 Conference Call（PDF/668KB）

ESG Meeting (2018)

• Nov. 20, 2018 ESG Meeting (Discussion with Investors)
• Nov. 20, 2018 Q&A Session at the ESG Meeting (Discussion with Investors)（PDF/121KB）

FY2017

Financial results for FY2017

• May 14, 2018 Financial Results for FY2017（PDF/878KB）
• Jan. 30, 2018 Financial Results for Q3 FY2017（PDF/1,035KB）
• Oct. 31, 2017 Financial Results for Q2 FY2017（PDF/888KB）
• Jul. 28, 2017 Financial Results for Q1 FY2017（PDF/924KB）

FY2016

Financial results for FY2016

• Financial Results for FY2016 (May 12, 2017)（PDF/1,390KB）
• Third Quarter Financial Results for FY2016 (January 27, 2017)（PDF/1,221KB）
• Second Quarter Financial Results for FY2016 (October 27, 2016)（PDF/1,119KB）
• First Quarter Financial Results for FY2016 (July 27, 2016)（PDF/843KB）

R&D Meeting (2017)

• R&D Meeting (February 28, 2017)

Acquisition of Tolero Pharmaceuticals, Inc.

• Acquisition of Tolero Pharmaceuticals, Inc. (December 21, 2016)（PDF/682KB）

FY2015

Financial results for FY2015

• Financial Results for FY2015 (May 12, 2016)（PDF/1,175KB）
• Third Quarter Financial Results for FY2015 (January 27, 2016)（PDF/1,385KB）
• Second Quarter Financial Results for FY2015 (October 29, 2015)（PDF/999KB）
• First Quarter Financial Results for FY2015 (July 29, 2015)（PDF/562KB）

R&D Meeting (2015)

• R&D Meeting (December 9, 2015)（PDF/4,424KB）

  Replaced slides of the R&D meeting presentation material as of December 9th (Revised: deleted the images of CT-scan on the slide 63 and 64)

FY2014

Financial results for FY2014

• Financial Results for FY2014 (May 12, 2015)（PDF/1,301KB）
• Third Quarter Financial Results for FY2014 (January 29, 2015)（PDF/1,018KB）
• Second Quarter Financial Results for FY2014 (October 31, 2014)（PDF/819KB）
• First Quarter Financial Results for FY2014 (July 30, 2014)（PDF/344KB）

FY2013

Financial results for FY2013

• Financial Results for FY2013 (May 9, 2014)（PDF/747KB）
• Third Quarter Financial Results for FY2013 (January 31, 2014)（PDF/593KB）
• Second Quarter Financial Results for FY2013 (October 31, 2013)（PDF/842KB）
• First Quarter Financial Results for FY2013 (July 31, 2013)（PDF/366KB）

R&D Meeting (2014)

• R&D Meeting (March 5, 2014)（PDF/1,527KB）

FY2012

Financial results for FY2012

• Financial Results for FY2012 (May 10, 2013)（PDF/357KB）
• Third Quarter Financial Results for FY2012 (January 31, 2013)（PDF/397KB）
• Second Quarter Financial Results for FY2012 (November 1, 2012)（PDF/663KB）
• First Quarter Financial Results for FY2012 (July 27, 2012)（PDF/287KB）

Third Mid-term Business Plan Presentation

• Third Mid-term Business Plan Presentation (February 19, 2013)(PDF/882KB)（PDF/803KB）

FY2011

Financial results for FY2011

• Financial Results for FY2011 (May 11, 2012)（PDF/679KB）
• Third Quarter Financial Results for FY2011 (February 3, 2012)（PDF/200KB）
• Second Quarter Financial Results for FY2011 (November 1, 2011)(Webcast Version)（PDF/287KB）
• First Quarter Financial Results for FY2011 (July 29, 2011)（PDF/190KB）

Acquisition of Boston Biomedical Inc.

• Acquisition of Boston Biomedical Inc. (February 29, 2012)（PDF/378KB）

J.P.Morgan Healthcare Conference 2012

• J.P.Morgan Healthcare Conference 2012 (January 9, 2012 San Francisco)（PDF/1,333KB）

FY2010

Financial results for FY2010

• Financial Results for FY2010 (May 12, 2011)（PDF/432KB）
• Third Quarter Financial Results for FY2010 (Apr. 1 to Dec. 31, 2010) (February 3, 2011)（PDF/219KB）
• Second Quarter Financial Results for FY2010 (Apr. 1 to Sep. 30, 2010) (November 2, 2010)（PDF/360KB）
• At the press conference, Second Quarter Financial Results for FY2010 (Apr. 1 to Sep. 30, 2010) (October 29, 2010)（PDF/344KB）
• First Quarter Financial Results for FY2010 (July 30, 2010)（PDF/348KB）

LATUDA® Meeting

• LATUDA® Meeting (January 25, 2011), Clinical Development Update（PDF/419KB）
• LATUDA® Meeting (January 25, 2011), Commercial Update（PDF/370KB）

J.P.Morgan Healthcare Conference 2011

• J.P.Morgan Healthcare Conference 2011 (January 11, 2011 San Francisco)（PDF/577KB）

FY2009

Financial results for FY2009

• Financial Results for FY2009 (May 11, 2010)（PDF/338KB）
• Third Quarter Financial Results for FY2009 (February 3, 2010)（PDF/270KB）
• Second Quarter Financial Results for FY2009 (October 29, 2009)（PDF/238KB）
• First Quarter Financial Results for FY2009 (July 31, 2009)（PDF/224KB）

Second Mid-term Business Plan　-FY2010 to FY2014-

• Second Mid-term Business Plan　-FY2010 to FY2014- (Feb. 16, 2010)（PDF/1,017KB）

Sepracor Inc. Company Overview

• Sepracor Inc. Company Overview -November 12, 2009（PDF/1,049KB）
• (Reference) Sepracor　Factbook 2009（PDF/1,573KB）

Acquisition of Sepracor Inc.

• Acquisition of Sepracor Inc. (September 3, 2009)（PDF/319KB）

Lurasidone Meeting

• Lurasidone Meeting (June 12, 2009)（PDF/1,180KB）

FY2008

Financial results for FY2008

• Financial Results for FY2008 (May 12, 2009)（PDF/444KB）
• Third Quarter Financial Results for FY2008 (Feb. 3, 2009)（PDF/220KB）
• Second Quarter Financial Results for FY2008 (October 31, 2008)（PDF/262KB）
• First Quarter Financial Results for FY2008 (July 31, 2008)（PDF/220KB）

FY2007

Financial results for FY2007

• Financial Results for FY2007 (May 12, 2008)（PDF/508KB）
• Third Quarter Financial Results for FY2007 (Feb. 1, 2008)（PDF/211KB）
• First Half Financial Results for FY2007 (Nov. 8, 2007)（PDF/275KB）
• Consolidated Financial Results for 1st Quarter of FY2007 (July 30, 2007)（PDF/216KB）

FY2006

Financial results for FY2006

• Financial Results for FY2006 (May 11, 2007)（PDF/290KB）
• Consolidated Financial Results for 3rd Quarter of FY2006 (Feb. 2, 2007)（PDF/292KB）
• First Half Financial Results for FY2006 (Nov. 9, 2006)（PDF/350KB）
• R&D Strategy for diabetes (Nov. 9, 2006)（PDF/255KB）
• Financial Results for the First Quarter of FY2006 (July 28, 2006)（PDF/214KB）

R&D Meeting (2007)

• R&D Meeting (March 28, 2007)（PDF/1,286KB）

FY'07-'09 Mid-term Business Plan

• FY'07-'09 Mid-term Business Plan (Feb. 28, 2007)（PDF/635KB）

FY2005

Financial results for FY2005

• Financial Results for FY2005 (May 12, 2006)（PDF/266KB）

R&D Meeting (2006)

• R&D Meeting (March 14, 2006)（PDF/1,361KB）